Y Intercept Hong Kong Ltd Has $1.61 Million Stock Position in STERIS plc $STE

Y Intercept Hong Kong Ltd lifted its holdings in shares of STERIS plc (NYSE:STE) by 652.7% in the 1st quarter, Holdings Channel reports. The institutional investor owned 7,286 shares of the medical equipment provider’s stock after acquiring an additional 6,318 shares during the period. Y Intercept Hong Kong Ltd’s holdings in STERIS were worth $1,611,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Board of the Pension Protection Fund acquired a new stake in STERIS during the 4th quarter worth $25,000. Activest Wealth Management boosted its position in shares of STERIS by 423.8% in the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 89 shares during the last quarter. Measured Wealth Private Client Group LLC acquired a new stake in shares of STERIS during the fourth quarter worth $28,000. Harbor Investment Advisory LLC grew its stake in shares of STERIS by 115.4% during the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 60 shares during the period. Finally, Cornerstone Planning Group LLC raised its position in shares of STERIS by 342.3% in the 4th quarter. Cornerstone Planning Group LLC now owns 115 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 89 shares during the period. 94.69% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CEO Daniel A. Carestio sold 1,374 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $212.00, for a total transaction of $291,288.00. Following the completion of the sale, the chief executive officer owned 63,647 shares of the company’s stock, valued at approximately $13,493,164. This represents a 2.11% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP John Adam Zangerle sold 1,419 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $209.28, for a total value of $296,968.32. Following the completion of the sale, the vice president directly owned 35,259 shares in the company, valued at approximately $7,379,003.52. This represents a 3.87% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,328 shares of company stock valued at $1,554,051 over the last 90 days. 1.12% of the stock is owned by corporate insiders.

STERIS Trading Up 3.1%

STERIS stock opened at $215.91 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.54 and a current ratio of 2.09. The stock has a 50-day simple moving average of $211.24 and a 200 day simple moving average of $230.56. The stock has a market capitalization of $21.04 billion, a P/E ratio of 27.23 and a beta of 0.92. STERIS plc has a 52 week low of $195.14 and a 52 week high of $269.44.

STERIS (NYSE:STE) last issued its quarterly earnings data on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share for the quarter, missing the consensus estimate of $2.86 by ($0.03). The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.59 billion. STERIS had a net margin of 13.18% and a return on equity of 14.15%. STERIS’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. Analysts expect that STERIS plc will post 11.18 earnings per share for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 26th. Investors of record on Monday, June 8th were paid a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Monday, June 8th. STERIS’s payout ratio is 31.78%.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Weiss Ratings cut STERIS from a “hold (c+)” rating to a “hold (c)” rating in a research note on Wednesday, May 27th. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 6th. Piper Sandler reiterated an “overweight” rating and set a $270.00 price objective on shares of STERIS in a report on Thursday, May 21st. Finally, KeyCorp decreased their price objective on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research report on Wednesday, May 13th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

STERIS Company Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.